Guidelines of the Spanish society of cardiology on interventional cardiology: Coronary angioplasty and other techniques;Guias de practica clinica de la sociedad Espanola de cardiologia en cardiologia intervencionista: Angioplastia coronaria y otras tecnicas

Revista Espanola de Cardiologia

Volumn 53, Issue 2, 2000, Pages 218-240

  Esplugas, Enrique ^a   Alfonso, Fernando ^b   Alonso, Joaquín J ^b   Asín, Enrique ^b   Elizaga, Jaime ^b   Íñiguez, Andrés ^b   Revuelta, José Manuel ^b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b NONE

Author keywords

Catheterization; Coronary angioplasty; Guidelines; Stent

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR;

ANGIOCARDIOGRAPHY; ATHERECTOMY; CORONARY ARTERY DILATATION; CORONARY STENT; HEART MUSCLE REVASCULARIZATION; INTRAVASCULAR ULTRASOUND; LASER ANGIOPLASTY; MEDICAL SOCIETY; PRACTICE GUIDELINE; REVIEW; SURGICAL TECHNIQUE; CARDIOLOGY; CARDIOVASCULAR SYSTEM EXAMINATION; DRUG ANTAGONISM; HUMAN; METHODOLOGY; SPAIN; STANDARD; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ATHERECTOMY, CORONARY; CARDIOLOGY; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; HUMANS; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; SPAIN; STENTS;

EID: 0034136931     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(00)75087-1     Document Type: Review

References (192)

1. Cohen MC, Eagle KA. Expert opinion regarding indications for coronary angiography before noncardiac surgery. Am Heart J 1997; 134: 321-329.
2. Iskandrian AS, Heo J. Optimizing patient selection for coronary angiography. Am J Cardiol 1995; 75: 14D-17D.
3. Mason JJ, Owens DK, Harris RA, Cooke JP, Hlatky MA. The role of coronary angiography and coronary revascularization before noncardiac vascular surgery. JAMA 1995; 273: 1919-1925.
4. Ayanian JZ, Landrum MB, Normand SL, Guadagnoli E, McNeil BJ. Rating the appropriateness of coronary angiography - do practicing physicians agree with an expert panel and with each other? N Engl J Med 1998; 338: 1896-1904.
5. Bengtson A, Herlitz J, Karlsson T, Brandrup-Wognsen G, Hjalmarson A. The appropriateness of performing coronary angiography and coronary artery revascularization in a Swedish population. JAMA 1994; 271: 1260-1265.
6. Bernstein SJ, Hilborne LH, Leape LL, Fiske ML, Park RE, Kamberg CJ et al. The appropriateness of use of coronary angiography in New York State. JAMA 1993; 269: 766-769.
7. Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA et al. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 1999; 33: 1756-1824.
8. Soriano J, Alfonso F, Cequier A, Morís C. Registro de actividad de la sección de hemodinámica y cardiología intervencionista del año 1997. Rev Esp Cardiol 1998; 51: 927-938.
9. Igual A, Saura E. Cirugía cardiovascular en España en el año 1996. Registro de intervenciones de la Sociedad Española de Cirugía Cardiovascular. Cir Cardiovas 1998; 5: 115-124.
10. Unger F. Worldwide survey on cardiac interventions 1995. Report of the European Heart Institute of the European Academy of Sciences and Arts. Cor Europaeum 1999; 7: 128-146.
11. Unger F. Cardiac Interventions in Europe 1996: Open Heart surgery and coronary revascularization. Report of the European Heart Institute of the European Academy of Sciences and Arts. Cor Europaeum 998; 7: 81-93.
12. Gruentzig AR. Transluminal dilation of coronary artery (letter to editor). Lancet 1978; 1: 263.
13. Proceedings of the National Heart, Lung, and Blood Institute Workshop on the outcome of Percutaneous Transluminal Coronary Angioplasty. Am J Cardiol 1984; 53 (special issue).
14. Maynard C, Chapko MK, Every NR, Martin DC, Ritchie JL. Coronary angioplasty in the healthcare cost and utilization project. Am J Cardiol 1998; 81: 848-852.
15. EPISTENT investigators. Randomized placebo-contolled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade. Lancet 1998; 9122: 87-92
16. Cowley MJ, Dorros G, Kelsey SF, Van Raden M, Detre KM. Acute coronary events associated with percutaneous transluminal coronary angioplasty. Am J Cardiol 1983; 53: 12C-16C.
17. Detre K, Ho ubkov R, Kelsey S, Cowley M, Kent K, Williams D et al. Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart, Lung and Blood Institute Registry. N Engl J Med 1988; 318: 265-270.
18. Ferguson JJ, Barasch E, Wilson JM, Strony J, Wolfe MW, Schweiger MJ. The relation of clinical outcome to dissection and thrombus formation during coronary angioplasty. J Invas Cardiol 1995; 7: 2-10
19. The Bypass Angioplasty Revascularization Investigation Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Eng J Med 1996; 335: 217-225.
20. Serruys PW. Arterial revacularization therapy study (ARTS). 71st Scientific Sessions of the American Heart Association. 9-12 de noviembre de 1998. Dallas.
21. Stone GW, Brodie BR, Griffin JJ, Morice MC, Costantini C, Goar FG et al for the PAMI stent pilot trial investigator. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in hospital and 30-day results of the PAMI stent pilot trial. J Am Coll Cardiol 1998; 31: 23-30.
22. Hannan EL, Racz M, Ryan TJ, McCallister BD, Johnson LW, Arani DT et al. Coronary angioplasty volume-outcome relationships for hospitals and operator in New York State: 1991-1994. JAMA 1997; 19: 277: 892-898.
23. Myler RK, Shaw RE, Stertzer SH, Hecht HS, Ryan C, Rosemblum J. Lesion morphology and coronary angioplasty: current experience and anlaysis. J Am Coll Cardiol 1992; 19: 1641-1652.
24. Serruys PW, De Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease: Benestent Study Group. N Engl J Med 1994; 331: 489-495.
25. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease: Stent Restenosis Study Investigators. N Eng J Med 1994; 331: 496-501.
26. Serruys PW, Van Hout B, Bonnier H, Legrand V, García E, Macaya C et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 1998; 352: 673-681.
27. Kimmel SE, Berlin JA, Strom BL, Laskey WE, for the Registry Committee of the Society for Cardiac Angiography and Interventions. Development and validation of a simplified predictive index for major complications in comtemporary percutaneous coronary angioplasty practice. J Am Coll Cardiol 1995; 26: 931-938.
28. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994; 330: 956-961.
29. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-doses heparin during percutaneous coronary revascularization. N Eng J Med 1997; 336: 1689-1696.
30. The CAPTURE Investigators. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study. Lancet 1997; 349: 1429-1435.
31. Brener SJ, Barr LA, Buchernal JE, Katz S, George BS, Jones AA et al. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction: ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators. Circulation 1998; 98: 734-741.
32. The IMPACT-II Investigators. Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Lancet 1997; 349: 1422-1428.
33. The RESTORE Study Group. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation 1997; 96: 1445-1453.
34. Alonso JJ, Durán JM, Gimeno F, De la Fuente L, Muñoz JC, Fernández-Avilés F. Tratamiento antitrombótico postimplante intracoronario de stent. Oclusión trombótica. Rev Esp Cardiol 1997; 50 (Supl 2): 31-43.
35. Alonso JJ, Durán JM, Gimeno F, Fernández-Avilés F. Tratamiento de la oclusión coronaria aguda y de la "amenaza de oclusión" postangioplastia coronaria mediante implante de prótesis intracoronarias o stent. Rev Esp Cardiol 1993; 46 (Supl 3): 97-109.
36. Masotti M, Serra A, Betriú A. Stent en lesiones coronarias de novo. Metanálisis. Rev Esp Cardiol 1997; 50 (Supl 2): 3-9.
37. Íñigez A. La reestenosis coronaria. Un problema no resuelto de la angioplastia coronaria transluminal percutánea. Rev Esp Cardiol 1993; 46 (Supl 3): 85-96.
38. Topol EJ, Ferguson JJ, Weisman HE, Tcheng JE, Ellis SG, Kleiman NS et al. Long-term protection from myocardial ischemic events in a randomized trial of brief integrin β3 blockade with percutaneous coronary intervention. JAMA 1997; 278: 479-484.
39. Valdés M, Pérez-Lorente F, López-Candel J. Eficacia del stent en las lesiones reestenóticas e injertos coronarios. Rev Esp Cardiol 1997; 50 (Supl 2): 10-20.
40. Cequier A, Mauri J, Gómez-Hospital JA, Sabaté M, Jara F, Esplugas E. Stent intracoronario en el tratamiento de las complicaciones de la angioplastia. Rev Esp Cardiol 1997; 50 (Supl 3): 21-30.
41. Alonso J, Arós LF, Íñiguez A, García E. Indicaciones de revascularización percutánea: angioplastia convencional y otras técnicas. En: Normas de Actuación Clínica en Cardiología. Madrid: Sociedad Española de Cardiología 1994; 185-193.
42. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association. J Am Coll Cardiol 1993; 22: 2033-2054.
43. Rihal CS, Gersh BJ, Yusuf S. Chronic coronary artery disease: coronary artery bypass surgery vs percutaneous transluminal coronary angioplasty vs medical therapy. En: Yusuf S de. Evidence based cardiology. Londres: BMJ Books 1998; 368-392.
44. Emanuelsso H, Brorsson H, Bernstein SJ, Werkö L. Coronary artery bypass graft surgery, percutaneous transluminal coronary angioplasty or medical therpy in anginal pain. A literature review for rating indications. Informe del The Swedish Council on Technology Assessment in Healt Care, Octubre de 1998.
45. Lázaro P, Fitch K, Martín Y. Estandares para el uso apropiado de la angioplastia coronaria transluminal percutánea y cirugía aortocoronaria. Rev Esp Cardiol 1998; 51: 689-715.
46. Bethencourt A, Fernández-Palomeque C, Gómez-Jaume A, Peral V. Revascularización precoz percutánea en los pacientes con angina inestable. Resultados actuales y comparación con el tratamiento médico conservador. Rev Esp Cardiol 1999; 52 (Supl 1): 117-130.
47. Fernández-Avilés F, De la Fuente L, Durán JM, Gimeno F, Ramos B, Alonso J, Garcimartín I. Papel de la angioplastia en los síndromes coronarios agudos en la era del stent. Rev Esp Cardiol 1999; 52 (Supl 1): 131-140.
48. Sanmartín M, Alfonso F. Cardiología basada en la evidencia: revascularización coronaria percutánea. Monocardio 1999; en prensa.
49. Parisi AF, Folland DE, Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992; 326: 10-16.
50. Hartigan PM, Giacomini JC, Folland ED, Parisi AF. Two to three-year follow-up of patients with single-vessel coronary artery disease randomized to PTCA or medical therapy (results of a VA cooperative study). Veterans Affairs Cooperative Studies Program ACME Investigators. Angioplasty Compared to Medicine. Am J Cardiol 1998; 82: 1445-1450.
51. RITA-2 trial participants. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. Lancet 1997; 350: 461-468.
52. Pitt B, Waters D, Brown WV, Van Boven AJ, Schwartz L, Title LM et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. N Engl J Med 1999; 341: 70-76.
53. Knatterud GL, Bourassa MG, Pepine CJ, Geller NL, Sopko G, Chaitman BR et al. Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the asymptomatic cardiac ischemica pilot (ACIP) study. J Am Coll Cardiol 1994; 24: 11-20.
54. Rogers WJ, Bourassa MG, Andrews TC, Bertolet BD, Blumenthal RS, Chaitman BR et al. Asymtomatic Cardiac Ischemia Pilot (ACIP)study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. J Am Coll Cardiol 1995; 26: 594-605.
55. RITA trial participants. Coronary angioplasty versus coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial. Lancet 1993; 341: 573-580.
56. Goy JJ, Eeckhout E, Burnand B, Vogt P, Stauffer JC, Hurni M et al. Coronary angioplasty versus left internal mammary artery grafting for isolated proximal left anterior descending artery stenosis. Lancet 1994; 343: 1449-1453.
57. Hueb WA, Bellotti G, De Oliveira SA, Arie S, De Albuquerque CP, Jatene AD et al. The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. J Am Coll Cardiol 1995; 26: 1600-1605.
58. Hueb W, Cardoso RH, Soares PR et al. The Medicine, Angioplasty and Surgery Study (MASS) a prospective randomised trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenosis, five years of follow-up. Circulation 1998; 98 (Supl I): 216 (abstract)
59. CABRI trial participants. First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularization Investigation). Lancet 1995; 346: 1179-1184.
60. King SB 3rd, Lembo NJ, Weintraub WS, Kosinski AS, Barnhart HX, Kutner MH et al. A randomized trial comparing coronary angioplasty versus Surgery Trial (EAST). N Engl J Med 1994; 331: 1044-1050.
61. Rodriguez A, Mele E, Peyregue E, Bullon F, Pérez-Balino N, Liprandi MI et al. Three-year follow-up of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Arery Bypass Surgery in Multivessel Disease (ERACI). J Am Coll Cardiol 1996; 27: 1178-1184.
62. Hamm CW, Reimers J, Ischinger T, Rupprecht HJ, Berger J, Bleifeld W et al. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease: German Angioplasty Bypass Surgery Investigation (GABI). N Eng J Med 1994; 331: 1037-1043.
63. Puel J, Karouny E, Marco F. Angioplasty versus surgery in multivessel disease: immediate results and in-hospital outcome in a randomized prospective study. Circulation 1992; 86 (Supl): I-372.
64. The BARI investigators. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease. The Bypass Angioplasty Revascularizacion Investigation (BARI). Circulation 1997; 96: 1761-1769.
65. Mark DB, Nelson CL, Califf RM, Harrell FE jr, Lee KL, Jones RH et al. Continuing evolution of therpy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation 1994; 89: 2015-2025.
66. Jones RH, Kesler K, Phillips HR 3rd, Mark DB, Smith PK, Nelson CL et al. Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. J Throrac Cardiovasc Surg 1996; 111: 1013-1025.
67. Lopez JJ, Ho KK, Stoler RC, Caputo RP, Carrozza JP, Kuntz RE et al. Percutaneous treatment of protected and unprotected left main coronary stenoses with new devices: immediate angiographic results and intermediate-term follow-up. J Am Coll Cardiol 1997; 29: 345-352
68. O'Keefe JH Jr, Hartzler GO, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV et al. Left main coronary angioplasty: early and late results of 127 acute and elective procedures. Am J Cardiol 1989; 54: 144-147.
69. Théroux P, Fuster V. Acute coronary syndromes. Unstable angina and non-Q-wave myocardial infarction. Circulation 1998; 97: 1195-1206.
70. Braunwald E, Jones RH, Mark DB, Brown J, Brown L, Cheitlin MD. Diagnosing and managing unstable angina. Circulation 1994; 90: 613-622.
71. ACC/AHA Guidelines for coronary angiography: executive summary and recomendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines (Committee on Coronary Angiography). Circulation 1999; 99: 2345-2357.
72. The Global Use Of Strategies To Open Occluded Coronary Arteries (GUSTO) IIb investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 1996; 335: 775-782.
73. Stammen F, De Scheerder I, Glazier JJ, Van Lierde J, Vrolix M, Willwms JL et al. Immediate and follow-up results of the conservative coronary angioplasty strategy for unstable angina perctoris. Am J Cardiol 1992; 69: 1533-1537.
74. Antoniucci D, Santoro GM, Bologuese L, Leoncini M, Buonamici P, Valenti R et al. Early coronary angioplasty as compared with delayed coronary angioplasty in patients wiyh high-risk unstable angina pectoris. Coron Artery Dis 1996; 7: 75-80.
75. Valdesuso RM, Íñiguez A, Córdoba M, Ayala R, Tarín N, Serrano JM et al. Revascularización percutánea mediante angioplastia coronaria en pacientes con angina refractaria. Rev Esp Cardiol 1996; 49: 826-833.
76. The TIMI IIIE Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB trial. Circulation 1994; 89: 1545-1556.
77. Anderson HV, Cannon CP, Stone PH, Williams DO, McCabe CH, Knatterud GL et al. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparisonof tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q-wave myocardial infarction. J Am Coll Cardiol 1995; 26: 1643-1650.
78. Boden WE, O'Rourke RA, Crawford MH, Blaustein AS, Deedwania PC, Zohlc RG et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med 1998; 338: 1785-1792.
79. McCullough PA, O'Neill WW, Graham M et al. A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial. J Am Coll Cardiol 1998; 32: 596-605.
80. Fragmin and Fast Revascularization during Instability in Coronary artery disease Investigators. Invasive compared with non-invasive treatment in unstable coronary-srtery disease: FRISC II prospective randomised multicenter study. Lancet 1999; 354: 708-715.
81. Wohlgelernter D, Cleman M, Highman HA, Zaret BL. Percutaneous transluminal coronary angioplasty of the "culprit lesion" for managements of unstable angina pectoris in patients with multivessel coronary artery disease. Am J Cardiol 1986; 58: 460-464.
82. De Feyter PJ, Serruys PW, Arnold A, Simoons ML, Wijns W, Geuskens R et al. Coronary angioplasty for unstable related vessel in patients with multivessel disease. Eur Heart J 1986; 7: 460-467.
83. Zijlstra F, De Boer MJ, Hoornje JC, Reiffers S, Reiber JH, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328: 680-684.
84. Ribeiro EE, Silva LA, Carneiro R, D'Oliveira LG, Gasquez A, Amino JG et al. Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. J Am Coll Cardiol 1993; 22: 376-380.
85. Grinfeld L, Berrocal D, Belardi J, et al. Fibrinolytics vs primary angioplasty in acute myocardial infarction (FAP): a randomized trial in a community hospital in Argentina. J Am Coll Cardiol 1996; 27: 222A (abstract)
86. Zijlstra F, Beukema WP, Van't Hof AW, Liem A, Reiflers S, Hoorntje JC et al. Randomized comparison of primary coronary angioplasy with thrombolytic therapy in low risk patients with acute myocardial infarction. J Am Coll Cardiol 1997; 29: 908-912.
87. DeWood MA. Direct PTCA vs intravenous t-PA in acute myocardial infarction: results from a prospective randomized trial. Thrombolysis and interventional therapy in acute myocardial infarction. George Washington University: VI Symposium. 1990; 28-29.
88. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993; 328: 673-679.
89. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJI. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993; 328: 685-691.
90. Ribichini F, Steffenino G, Dellavalle A, Ferrero V, Vado A, Feola M et al. Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depression: immediate and long-term results of a randomized study. J Am Coll Cardiol 1998; 32: 1687-1694
91. Garcia E, Elizaga J, Pérez-Castellano N, Serrano JA, Soriano J, Abeytua et al. Primary angioplasty versus systemic thrombolysis anterior myocardial infarction. J Am Coll Cardiol 1999; 33: 605-611.
92. GUSTO IIb Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997; 336: 1621-1628.
93. Weaver WD, Simes RJ, Betriu A, Grines CL, Zijlstra F, Garcia E et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 1997; 278: 2093-2098.
94. Every NR, Parson LS, Hlatky M, Martin JS, Weaver WD. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. N Engl J Med 1996; 335: 1253-1260.
95. Tiefenbrunn J, Chandra NC, French WJ, Gore IM, Rogers WJ. Clinical experience with primary PTCA compared with alteplase (rtPA) in patients with acute myocardial infarction. J Am Coll Cardiol 1998; 31: 1240-1245.
96. ACC/AHA Guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Prectice guidelines (Committee on Management of Acute Myocardial Infaction). J Am Coll Cardiol 1996; 28: 1328-1428.
97. Ross AM, Lundergan CF, Rhorbeck SC, Boyle DH, van den Brand M, Buller CH et al. Rescue angioplasty after failed thrombolysis: technical and clinical outcomes in a large thrombolysis trial. GUSTO-1 Angiographic Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1998; 31: 1511-1517.
98. Ellis SG, Da Silva ER, Heyndinckx G, Talley JD, Cernigliano C, Steg G et al. Randomized comparison of rescue angioplasty with conservative managament of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation 1994; 90: 2280-2289.
99. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogecnic shock. N Engl J Med 1999; 341: 625-634.
100. Madsen JK, Grande P, Saunamaki K, Thayssen P, Kassis E, Eriksen U et al. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction. Circulation 1997; 96: 748-755.
101. Topol EJ. Coronary artery stents. Gauging, gorging and gouging. N Engl J Med 1998; 339: 1702.
102. Sigwart U, Urban P, Golf S, Kaufmann U, Imbert C, Fischer A, et al. Emergency stenting for acute occlusion after coronary balloon angioplasty. Circulation 1988; 78: 1121-1127.
103. Roubin GS, Cannon AD, Agrawal SK, Macander PJ, Dean SL, Baxley WA et al. Intracronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 1992; 85: 916-927.
104. George BS, Voorhees WE III, Roubin GS, Fearnot NE, Pinkeston CA, Rainzner AL et al. Multicenter investigation of coronary stenting to treat acute of threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes. J Am Coll Cardiol 1993; 88: 2086-2096.
105. Ray SG, Penn IM, Ricci DR, Barth J, Mancini GB, Buller CE et al. Mechanisms of benefit of stenting in failed angioplasty. Final results from the trial of Angioplasty and stents in Canada (TASC II). J Am Coll Cardiol 1995; 25: 156A.
106. Keane DK, Roubin GS, Marco J et al. GRACE Gianturco-Roubin stent Acute Closure Evaluation: substrate, challenges, and design of a randomized trial of bailout management. J Interven Cardiol 1994; 7: 333-339.
107. Haude M, Erbel R, Höepp HW, Heublein HB, Sigmund M, Meyer J et al. STENT-BY Study: a prospective randomised trial comparing immediate stenting versus conservative treatment strategies in abrupt vessel closure of symptomatic dissections during coronary balloon angioplasty. Eur Heart J 1996; 17 (Supl): 172.
108. Esplugas E, Hernández-Antolín R. López-Bescós L, Moreu J, Pomar JL. Realización de angioplastias coronarias en centros sin cirugía cardíaca. Recomendaciones de la Sociedad Española de Cardiología. Rev Esp Cardiol 1999; 52: 5-12.
109. Danchin N, Daclin V, Juilliere Y, Dibon O, Bischott N, Pinelli G, et al. Changes in patients treatment after abrupt closure complicating percutaneous transluminal coronary angioplasty: a historic perspective. Am Heart J 1995; 130: 1158-1163.
110. Altmann DB, Racz M, Battleman DS, Bergman G, Spokojny A, Hannan EZ et al. Reduction in angioplasty complications after the introduction of coronary stents: results from a consecutive series of 2242 patients. Am Heart J 1996; 132: 503-507.
111. Macaya C, Serruys PW, Ruygrok P, Suryapranata H, Mast G, Klugmanns, K et al. Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of Benestent trial: Benestent Study Group. J Am Coll Cardiol 1996; 27: 255-261.
112. Masotti M, Serra A, Fernandez-Aviles F, Alonso J, Gimeno F, Colman T et al. Is the initial benefit of stenting sustained over the years? Long-term results of the START trial. Circulation 1998; 98 (Supl I): 2623 (abstract).
113. Versaci F, Gaspardone A, Tomai F, Crea F, Chiariello L, Siottre PA et al. A comparison of coronary artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. N Engl J Med 1997; 336: 817-822.
114. Phillips PS, Segovia J, Alfonso F, Goicolea J, Hernández R, Bañuelos C et al. Advantage of stents in the most proximal left anterior descending coronary artery. Am Heart J 1998; 135: 719-725.
115. Medina A, Melian F, Suarez de Lezo J, Pan M, Romero M, Hernandez E et al. Effectiveness of coronary stenting for the treatment of chronic total occlusion in angina pectoris. Am J Cardiol 1994; 73: 1222-1224
116. Sirnes PA, Golf S, Myreng Y, Molstad P, Alberstsson P, Mangschau A et al. Sustained benefit of stenting chronic coronary occlusion: long-term clinical follow-up of the Stenting in Chronic Coronary Occlusion (SICCO) study. J Am Coll Cardiol 1998; 32: 305-310.
117. Rubartelli P, Niccoli L, Verna E, Giachero C, Zimarino M, Fontanelli A et al. Stent implantation versus balloon angioplasty in chronic coronary occlusions: results from the GISSOC trial. Gruppo Italiano di Studio sullo Stent nelle Occlusioni Coronariche. J Am Coll Cardiol 1998; 32: 90-96.
118. Hancock J, Thomas MR, Holmberg S, Wainwright RJ, Jewitt DE. Randomised trial of elective stenting after successful percutaneous transluminal coronary angioplasty of occluded coronary arteries. Heart 1998; 79: 18-23.
119. Erbel R, Haude M, Hopp HW, Francen D, Rupprecht HJ, Heublein B et al. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. N Engl J Med 1998; 339: 1672-1678.
120. Savage MP, Douglas JS Jr, Fischman DE, Pepine CJ, King SB, Werner JA et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphcnous Vein De Novo Trial Investigators. N Engl J Med 1997; 337: 740-747.
121. Gomez Recio M, García E, Pasalodos J, Merchán A, Tascón J, Fernández-Vallejo V, por los investigadores del estudio RAP. Análisis intermedio de un estudio randomizado que compara stent con angioplastia convencional en vasos pequeños. Rev Esp Cardiol 1998; 51: 91.
122. Park SJ, Park SW, Hong MK, Cheongs S, Lee CW, Kim JJ et al. Stenting of unprotected left main coronary artery stenoses: immediate and late outcome. J Am Coll Cardiol 1998; 31: 37-42.
123. Alfonso F, Rodriguez P, Phillips P, Goicolea J, Hernández R, Pérez-Vizcayno MJ et al. Clinical and angiographic implications of coronary stenting in thrombus-containing lesions. J Am Coll Cardiol 1997; 29: 725-733.
124. Kaul U, Agarwal R, Jain P, Wasir H. Safety and efficacy of intracoronary stenting for thrombus-containing lesions. Am J Cardiol 1996; 77: 425-427.
125. Ferguson JJ. Meeting Highlights. 47th Annual Scientific Sessions of the American College of Cardiology. Circulation 1998; 97: 2377-2381.
126. Suryapranata H, Van't Hof AWJ, Hoorntje JC, De Boer MJ, Zijlstra F. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998; 97: 2502-2505.
127. Antoniucci D, Santoro GM, Bolognese L, Valenti R, Trapani M, Fazzini PF et al. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) trial. J Am Coll Cardiol 1998; 31: 1234-1239.
128. Rodríguez A, Bernardi V, Fernández M, Mauvencin C, Ayala F, Santaera O et al. In-hospital and late results of coronary stents versus conventional balloon angioplasty in acute myocardial infarction (GRAMI trial). Am J Cardiol 1998; 81: 1286-1291.
129. Narins CR, Holmes DR, Topol EJ. A call for provisional stenting. The balloon is back! Circulation 1998; 97: 1298-1305.
130. Serruys P, Azar A, Sigwart U, Rutsch, De Jaegere P, Kiemenij F et al. Long-term follow-up of "stent-like" (< 30% diameter stenosis post) angioplasty: a case for provisional stenting. J Am Coll Cardiol 1996; 27 (Supl A): 15A
131. Holmes DR Jr, Kip KE, Yeh W, Kelsey SF, Detre KM, Williams Do et al. Long-term analysis of conventional coronary balloon angioplasty and an initial "stent-like" result. The NHL-BI PTCA Registry. J Am Coll Cardiol 1998; 32: 590-595.
132. Rodriguez A, Ayala F, Bernardi V, Santaeva O, Marchand E, Pardines C et al. Optimal coronary balloon angioplasty with provisional stenting versus primary stent (OCBAS): immediate and long-term follow-up results. J Am Coll Cardiol 1998; 32: 1351-1357.
133. Schomig A, Neumann FJ, Kastrati A, Schuhlen H, Blasini R, Hadamitzky M et al. A randomized comparison of antiplatelet and anticoagulation therapy after the placement of coronary artery stents. N Engl J Med 1996; 334: 1084-1089.
134. Bertrand ME, Legrand V, Boland J, Fleck E, Bonnier J, Emmanuelsson H et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (FANTASTIC) study. Circulation 1998; 98: 1597-1603.
135. Urban P, Macaya C, Rupprecht HJ, Kiemeneij F, Emmanuelsson H, Fontanelli A et al. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients. The multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS). Circulation 1998; 98: 2126-2132.
136. Leon MB, Baim DS, Popma JJ, Gordon PC. Cutlip DE, Ho KKL et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. N Engl J Med 1998; 339: 1665-1671.
137. Mintz GS, Hoffmann R, Mehran R, Pichard AD, Kent KM, Satler LF, Popma JJ, Leon MB. In-stent restenosis: the Washington hospital center experience. Am J Cardiol 1998; 81: 7E-13E.
138. Reimers B, Mcussa I, Akiyama T, Tucci G, Ferraro M, Martini G, Blengino S, Di Mario C, Colombo A. Long-term clinical follow-up after successful repeat percutaneous intervention for stent restenosis. J Am Coll Cardiol 1997; 30: 186-192.
139. Bauters C, Banos JL, Van Belle E, Fadden EP, Lablanche JM, Bertrand ME. Six-month angiographic outcome after successful repeat percutaneous interventionfor in-stent-restenosis. Circulation 1998; 97: 318-321.
140. Alfonso F, Perez-Vizcayno MJ, Hernandez R, Goicolea J, Fernandez-Ortiz A, Escaned J, Bañuelos C, Fernandez C, Macaya C. Long-term outcome and determinants of event-free survival in patients treaied with balloon angioplasty for in-stent restenosis. Am J Cardiol 1999; 83: 1268-1270.
141. Mahdi NA, Pathan AZ, Harrell L, Leon MN, Lopez J, Butte A, Ferrell M, Gold HK, Palacios IF. Directional coronary atherectomy for the treatment of Palmaz-Schatz in-stent restenosis. Am J Cardiol 1998; 82: 1345-1351.
142. Lee SG, Lee CW, Cheong SS, Hong MK, Kim JJ, Park SW, Park SJ. Immediate and long-term outcomes of rotational atherectomy versus balloon angioplasty alone for treatment of diffuse in-stent restenosis. Am J Cardiol 1998; 82: 140-143.
143. Dauerman HL, Bain DS, Cutlip DE, Sparano AM, Gibson CM, Kuntz RE, Carroza JP, Garber GR, Cohen DJ. Mechanical debulking versus balloon angioplasty for the treatment of diffuse in-stent restenosis. Am J Cardiol 1998; 82: 277-284.
144. Mehran R, Mintz GS, Satler LF, Pichard AD, Kent M, Bucher TA et al. Treatment of in-stent restenosis with excimer laser coronary angioplasty: mechanisms and results compared with PTCA alone. Circulation 1997; 96: 2183-2189.
145. Zueco J, Bethencourt A, Pasalodos J, Cequier A, Gómez-Recio M, Auge JM, Castillo JL, Hernández JM, Alfonso K. Implantación electiva de stent versus angioplastia con balón en el tratamiento de la reestenosis intra-stent. Diseño y datos preliminares de un estudio multicéntrico y randomizado. Rev Esp Cardiol 1998; 52 (Supl 5): 16.
146. Topol EJ, Leya F, Pinkerton CA et al. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med 1993; 329: 221-227.
147. Adelman AG, Cohen EA, Kimball BP, Bonan R, Ricci DK, Webb JG et al. A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending artery. N Engl J Med 1993; 329: 228-233.
148. Baim DS, Cutlip DE, Sharma SK, Ho KKL, Fortuna R, Schreiber TL et al. Final besults of the Balloon vs Optimal Atherectomy Trial (BOAT). Circulation 1998; 97: 322-331.
149. Holmes DR, Topol EJ, Califf RM, Bardan LG, Leya F, Berger PB et al. A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. Circulation 1995; 91: 1966-1974.
150. Moussa I, Moses J, Di Mario C, Busi G, Reimers B, Kobayashi Y et al. Stenting after Optimal Lesion Debulking (SOLD) registry angiography and clinical outcome. Circulation 1998; 98: 1604-1609.
151. Brown DL, George CJ, Steekiste AR, Cowley MJ, Leon MB, Cleman MW et al. High-speed rotational atherectomy of human coronary stenoses: acule and one-year outcomes from the New Approaches to Coronary Intervention (NACI) registry. Am J Cardiol 1997; 80 (10A): 60K-67K.
152. Reifart N, Vundormael M, Krajcar M, Sohring S, Preusler W, Schwarz F et al. Randomized comparison of angioplasty of complex coronary lesions at a single center. Excimer laser, rotational atherectomy, and balloon angioplasty comparison (ER-BAC) study. Circulation 1997; 96: 91-98.
153. Whitlow PL, Cowley MJ, Kuntz RE, Williams DO, Bass TA, Kipper, An RM et al. Study to determine rotablator and transluminal angioplasty strategy - acute results. Circulation 1996; 94: I-344.
154. Sketch MH, Davidson CJ, Yeh W, Margolis JR, Matthews RV, Moses JW et al. Predictors of acute and long-term outcome with transluminal extraction atherectomy: the New Approaches to Coronary Intervention (NACI) registry. Am J Cardiol 1997; 80 (10A): 68K-77K.
155. Barath P, Fishbein MC, Van S, Forrester JS. Cutting balloon: a novel approach to percutaneous angioplasty. Am J Cardiol 1991; 68: 1249-1252.
156. Kondo T, Kawaguchi K, Awaji Y, Mochizuki M. Immediate and chronic results of cutting balloon angioplasty: a matched comparison with conventional angioplasty. Clin Cardiol 1997; 20: 459-463.
157. Moris C. Bethencourt A, Gomez-Recio M. Angiographic follow-up of the cutting balloon vs conventional balloon angioplasty study. Results of the CUBA study. J Am Coll Cardiol 1998; 31: 865A.
158. Kurbaan AS, Kelly PA, Sigwart U. Cutting balloon angioplasty and stenting for aorto-ostial lesions. Heart 1997; 77: 350-352.
159. Asakura Y, Furukawa Y, Ishikawa S, Asakura K, Sueyoshi K, Sakamoto M et al. Successful predilation of a resistant, heavily calcified lesion with cutting balloon for coronary stenting: a case report. Cathet Cardiovasc Diagn 1998; 44: 420-422
160. Stone GW, Marchena E, Dageforde D, Foschi A, Muhlestein JB, McIvor M et al. Prospective, randomized, multicenter comparison of laser-facilitated balloon angioplasty versus stand-alone balloon angioplasty in patients with obstructive coronary artery disease. J Am Coll Cardiol 1997; 30: 1714-1721.
161. Kim CB, Kesten R, Javier M, Hayase M, Walton AS, Billingham ME et al. Percutaneous method of laser transmyocardial revascularization. Cathet Cardiovasc Diagn 1997; 40: 223-228.
162. Schofield PM, Sharples LD, Caine N, Burns S, Tait S, Buxton M, Wallwork J. Transmyocardial laser revascularization in patients with refractory angina: a randomised controlled trial. Lancet 1999; 353: 519-524
163. Teirstein PS, Massullo V, Jani S, Popma JJ, Mintz GS, Russo RJ et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997; 336: 1697-1703.
164. King III SB, Williams DO, Chougule P, Klein JL, Waskman R, Hilstead R et al. Endovascular β-radiation to reduce restenosis after coronary balloon angioplasty. Results of the Beta Energy Restenosis Trial (BERT). Circulation 1998; 97: 2025-2030.
165. The Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Inverstigators. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Eng J Med 1998; 338: 1498-1505.
166. The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) study investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Eng J Med 1998; 338: 1488-1497.
167. The PARAGON Investigators. Analitica international, randomized, controlled trial of lamifiban, a platelet glycoprotein IIb/IIIa inhibitor, heparin or both in unstable angina. Circulation 1998; 97: 2386-2395.
168. The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Eng J Med 1998; 339: 436-443.
169. Topol EJ, Califf RM, Weisman HF, Ellis SG, Tcheng JE, Worley S et al. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet 1994; 343: 881-886.
170. Lincoff AM, Califf RM, Anderson KM, Weisman HF, Aguirre FV, Kleiman NS et al. Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abcisimab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization. J Am Coll Cardiol 1997; 30: 149-156.
171. Braunwald E, Maseri A, Armstrong PW, Califf RM, Gibler WB, Hamm CW et al. Rationale and clinical evidente for the use of GP IIb/IIIa inhibitors in acute coronary syndromes. Eur Heart J 1998; 19 (Supl D): D22-D30.
172. Chronos N, Vahanian A, Betriu A, Amanuelsson H, Goldberg S, Gulba D et al. Use of abciximab in interventional cardiology. Eur Heart J 1998; 19 (Supl D): D31-D39.
173. King III SB, Klein L, Williams DO, Bonan R, Waskman R, Crocker IR et al. The Beta Energy Restenosis Trial: updated results and subgroup analysis. Circulation 1998; 98 (Supl 1): 3.420-A (abstract).
174. Nishimura RA, Edwards WD, Warnes CA, Reeder GS, Holmes DR et al. Intravascular ultrasound imaging: in vitro validation and pathologic correlation. J Am Coll Cardiol 1990; 16: 145-154.
175. Nissen SR, Gurley JC, Grines CL, Booth DC, McClure R, Berk M et al. Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation 1991; 84: 1087-1099.
176. Lansky AJ, Mintz GS, Popma JJ, Richard AD, Kent KM, Satler LF et al. Remodeling after directional coronary atherectomy (with and without percutaneous adjunct transluminal angioplasty) a serial angiographic and intravascular ultrasound analysis for the optimal atherectomy restenosis study. J Am Coll Cardiol 1998; 32: 329-337.
177. Stone GW, Hodgson JM, St Goar FG, Frey A, Mudra H, Sheehan H, Linnemeier TJ. Improved procedural results of coronary angioplasty with intravascular ultrasound guided balloon sizing: the CLOUT pilot trial. Circulation 1997; 95: 2044-2052.
178. Colombo A, Hall P, Nakamura S, Almager Y, Maiello L, Martini G et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995; 91: 1676-1688.
179. Karrillo GJ, Morice MC, Benveniste E, Bunouf P, Aubry P, Cattan S et al. Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy. 30-day clinical outcome of the French multicenter registry. Circulation 1996; 94: 1519-1527.
180. Bermejo J, Botas J, Garcia E, Elizaga E, Osende J, Soriano J, Abeytua M, Delcán JL. Mechanisms of residual lumen stenosis after high pressure stent implantation: a quantitative angiography and intravascular ultrasound study. Circulation 1998; 98: 112-118.
181. Russo RJ, Wong SC, Lucisano JE, Silva P, Ling FS, Fitzgerald PJ et al. Angiography versus Intravascular Ultrasound assessment of coronary stent placement: observations from the AVID study. J Am Coll Cardiol 1998; 31: 896A
182. Hayase M, Oshima A, Cleman M, Pepine CJ, Bailey SR, Shani J et al. Relation between target vessel revascularization and minimum stent area by intravascular ultrasound. CRUISE trial. J Am Coll Cardiol 1998; 31: 386A.
183. Mudra H, Macaya C, Zahn R, Grip L, Di Mario C, Rutsch W et al. Interim analysis of the "OPTimization with ICUS to reduce stent restenosis" (OPTICUS) trial. Circulation 1998; 98 (Supl I): I-363.
184. Schiele F, Meneveau N, Vuillemenot A, Zhang DD, Gupta S, mercier M et al. Impact of intravascular ultrasound guidance in stent deployment on 6-month restenosis rate: a multicenter, randomized study comparing two strategies - with and without intravascular ultrasound guidance. J Am Coll Cardiol 1998; 32: 320-328.
185. Mizuno K, Satomura K, Miyamoto A, Ko A, Shibuya T, Tsnenovi A et al. Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. N Engl J Med 1992; 326: 287-291.
186. Alfonso F, Goicolea J, Hernandez R, Goncalves M, Segovia J, Bañuelos C et al. Angioscopic findings during coronary angioplasty of coronary occlusions. J Am Coll Cardiol 1995; 26: 135-141.
187. Ferrari M, Schnell B, Werner GS, Figula HR. Safety of defering angioplasty in patients with normal coronary flow velocity reserve. J Am Coll Cardiol 1999; 33: 82-87.
188. Kern MJ, Donohue TJ, Aguirre FU, Barch RC, Cavacciolo EA, Wolford T et al. Clinical outcome of deferring angioplasty in patients with normal translesional pressure-flow velocity measurements. J Am Coll Cardiol 1995; 25: 178-187.
189. Serruys PW, Di Mario C, Piek J, Schroeder E, Vrints C, Probst P et al. Prognostic value of intracoronary flow velocity and DS in assessing the short and long-term outcome of coronary balloon angioplasty. The DEBATE Study (Doppler Endpoints Balloon Angioplasty Trial Europe). Circulation 1997; 96: 3369-3377.
190. Pijls NHJ, Van Gelder B, Van Der Voort P, Peels K, Bracke F, Bonnier HJ et al. Fractional flow reserve: a useful index to evaluate the influence of a epicardial coronary stenosis on myocardial blood flow. Circulation 1995; 92: 3183-3193.
191. Pijls NHJ, De Bruyne B, Peels K, Van Der Voort PH, Bonnier HJ, Koolen JJ, Bartunek J. Measurement of fractional flow reserve to assess the functional seventy of a coronary-artery stenoses. N Engl J Med 1996; 334: 1703-1708.
192. Bech GJW, Pijls N, De Bruyne BD, Peels KH, Michels R, Bonnier HJ et al. Usefulness of fractional flow reserve to predict clinical outcome after balloon angioplasty. Circulation 1999; 99: 883-888.